Cutaneous adverse
Cutaneous adverse
CHAPTER 14
reactions to drugs
ADVERSE DRUG REACTIONS
Purpuric drug reactions 649 Granulomatous drug reactions 649 Drug-induced erythema nodosum 651 Drug-induced alopecia 651 Drug-induced lupus erythematosus 651 Bullous drug reactions 651 Drug-induced linear IgA disease 651 Drug-induced bullous pemphigoid 652 Drug-induced epidermolysis bullosa acquisita 653 Drug-induced pemphigus 653 Drug-induced pseudoporphyria 653 Psoriasiform drug reactions 654 Pityriasiform drug reactions 654 Pustular drug reactions 655 Ichthyosiform drug reactions 656 Drug-induced pseudolymphoma 656 Specific drug reactions 659 Arsenic 659 Iododerma 659 Bromoderma 660 Warfarin 661 Heparin 662 Penicillamine 662 Gold 662 Silver 663
– INTRODUCTION 633 Type A drug reactions 634 Type B drug reactions 634 Type C drug reactions 634
ADVERSE DRUG REACTIONS – CLINICAL
MANIFESTATIONS 635 Exanthematous reactions 635 Urticarial reactions, angioedema and
Mercury 664 Bismuth 665 Voriconazole 665 Lithium 665 Barbiturates and coma blisters 665 Chemotherapeutic agents 666 Chemotherapy-induced acral erythema 671 Chemotherapy-associated eccrine gland
reactions 671 Neutrophilic eccrine hidradenitis 672 Eccrine squamous syringometaplasia 673 Adverse reactions to cytokine therapy 673 Cutaneous reaction of lymphocyte
anaphylaxis 637 Serum sickness/serum sickness-like drug
reactions 637 Phototoxic and photoallergic reactions 638 Drug reaction with eosinophilia and
systemic symptoms 640 Lichenoid and interface drug reactions 642 Fixed drug eruptions 643 Erythema multiforme 644 Stevens-Johnson syndrome and toxic
epidermal necrolysis 645 Drug-induced hyperpigmentation 645 Vasculitic drug reactions 648
recovery 674 Dental amalgam tattoos 674 Tumor necrosis factor-α inhibitors 674 Esthetic microimplants 676 Aluminum granuloma 679 Adverse reactions to corticosteroid
injections 680 Alpha-melanocyte stimulating hormone
analogues (melanotan I and II) 680 EMLA cream (prilocaine-lidocaine
emulsion) 680